Search

everythinglearnresearchcommunity

for

Search:↓

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Scalp cooling helps prevent hair loss during chemotherapy for breast cancer.

Some chemotherapy can cause permanent hair loss.

Ultrasound and nanocarriers could make breast cancer treatment safer and more effective.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

Most patients treated with trastuzumab and paclitaxel experience some hair loss, but it's usually not severe.

Boosting certain cell signals can prevent hair loss from chemotherapy and radiation.

A thorough diagnostic process and teamwork are crucial for managing complex hyperandrogenism in postmenopausal women.

Photodynamic therapy was effective in treating multiple scalp basal cell carcinomas with minimal side effects and good cosmetic results.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Permanent hair loss from chemotherapy significantly impacts patients' mental health and social life, highlighting the need for better patient education and support.

Alternative therapies like mushrooms and vinegar extracts can improve health and reduce costs for breast cancer patients.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Bevacizumab may worsen hypothyroidism, so thyroid function should be monitored during treatment.

A woman's hair grew back after treatment for a rare hair loss caused by proton therapy.

Pulsed electric field treatment may help shrink untreated liver tumors.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

FLASH radiation reduces tissue damage more than conventional radiation.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

HPV infection is linked to better survival in advanced anal cancer, higher radiation doses improve survival, especially in HPV-negative patients, and prostaglandin E₂ pretreatment can protect mouse hair follicles from radiation damage.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Activating certain hair follicle cells could prevent hair loss from cancer treatments.

Chemotherapy worsens nutritional status in breast cancer patients, requiring targeted nutritional strategies.

Careful planning and technique are crucial for successful hair transplants on irradiated scalps.

Vijaya successfully fought stage 2A breast cancer with surgery, chemotherapy, radiotherapy, and hormone therapy, while advocating for support groups.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

Scalp cooling effectively prevents hair loss in breast cancer patients undergoing chemotherapy.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.